Patología Hepática immediately after liver transplantation. Hepatology 2002; 35: 680-7. 15.- Bruno S, Crosignani A, Maisonneuve P, Rossi S, Silini E, Mondelli MU. Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study. Hepatology 2007; 46: 1350-6. 16.- Reig M, Mariño Z, Perelló C, Iñarrairaegui M, Ribeiro A, Lens S, et al. S 68 Tratamient o de la Hepatiti s C en cirr osis - A. Ruiz S. et al. Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular carcinoma undergoing interferon-free therapy: a note of caution. J Hepatol 2016; S0168- 8278(16)30113-1 Publicación electrónica en avance. 17.- The ANRS collaborative study group on hepatocellular carcinoma (ANRS CO22 HEPATHER, CO12 CIRVIR and CO23 CUPILT cohorts). Lack of evidence of an effect of Direct Acting Antivirals on the recurrence of hepatocellular carcinoma: Data from the ANRS cohorts. J Hepatol 2016; S0168-8278(16)30259-8 Publicación electrónica en avance. 18.- de Franchis R, Baveno VIF. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63: 743-52. Gastroenterol. latinoam 2016; Vol 27, S upl Nº 1: S 64-S 68
Gastro_3
To see the actual publication please follow the link above